SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-008918
Filing Date
2021-05-04
Accepted
2021-05-04 17:21:37
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q espr-20210331.htm   iXBRL 10-Q 991136
2 EX-3.1 ex31-secondamendedandresta.htm EX-3.1 136736
3 EX-10.1 ex1012ndamendmentdseagreem.htm EX-10.1 142375
4 EX-31.1 espr-ex311x03312021.htm EX-31.1 11049
5 EX-31.2 espr-ex312x03312021.htm EX-31.2 11128
6 EX-32.1 espr-ex321x03312021.htm EX-32.1 7606
  Complete submission text file 0001628280-21-008918.txt   5929034

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20210331.xsd EX-101.SCH 49764
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20210331_cal.xml EX-101.CAL 64601
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20210331_def.xml EX-101.DEF 256445
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20210331_lab.xml EX-101.LAB 586299
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20210331_pre.xml EX-101.PRE 386529
12 EXTRACTED XBRL INSTANCE DOCUMENT espr-20210331_htm.xml XML 788007
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 21889930
SIC: 2834 Pharmaceutical Preparations